Cincinnati-Based Medpace Prices $161 Million IPO

Published: Aug 02, 2016

Contract research organization Medpace today released the pricing for its initial public offering, looking to float 7 million shares at between $20 and $23 per share, which will bring in between $140 and $161 million.

Private equity shop Cinven paid CCMP Capital Advisors $921.3 million for Cincinnati-based Medpace in 2014. The company originally registered for the $150 million IPO in late June, saying it plans to use to pay down some of its debt.

Back to news